Vegetable and fruit intake after diagnosis and risk of prostate cancer progression

International Journal of Cancer

Volumn 131, Issue 1, 2012, Pages 201-210

  Richman, Erin L ^a,b   Carroll, Peter R ^b,c   Chan, June M ^b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cruciferous; fruit; prostate cancer; survivorship; vegetables

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FOOD; FOOD ANALYSIS; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; FRUIT; HUMAN; LEGUME; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENCE RISK; RISK REDUCTION; TOMATO SAUCE; UNITED STATES; VEGETABLE;

DISEASE PROGRESSION; EATING; FOOD HABITS; FRUIT; HUMANS; MALE; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK; RISK FACTORS; VEGETABLES;

EID: 84860222189     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26348     Document Type: Article

References (50)

1. National Cancer Institute. Prostate. In:, Results SEaE, ed., SEER Stat Fact Sheets, vol. 2011. Bethesda: National Cancer Institute, 2010. Available online at.
2. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC,. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007; 121: 1571-8.
3. Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA,. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 2004; 93: 1139-50.
4. Chan JM, Gann PH, Giovannucci EL,. Role of diet in prostate cancer development and progression. J Clin Oncol 2005; 23: 8152-60.
5. Platz E, Giovannucci E,. Prostate cancer. In:, Schottenfeld D, Fraumeni F, eds. Cancer epidemiology and prevention, 3rd edn. New York: Oxford University Press, 2006. 1128-50.
6. World Cancer Research Fund and American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. World Cancer Research Fund and American Institute for Cancer Research, Washington DC, 2007.
7. Chan JM, Holick CN, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Giovannucci EL,. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control 2006; 17: 199-208.
8. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM,. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr 2010; 91: 712-21.
9. Strom SS, Yamamura Y, Forman MR, Pettaway CA, Barrera SL, DiGiovanni J,. Saturated fat intake predicts biochemical failure after prostatectomy. Int J Cancer 2008; 122: 2581-5.
10. Meyer F, Bairati I, Shadmani R, Fradet Y, Moore L,. Dietary fat and prostate cancer survival. Cancer Causes Control 1999; 10: 245-51.
11. Van Patten CL, de Boer JG, Tomlinson Guns ES,. Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. J Urol 2008; 180: 2314-21; discussion 721-2.
12. Schroder FH, Roobol MJ, Boeve ER, de Mutsert R, Zuijdgeest-van Leeuwen SD, Kersten I, Wildhagen MF, van Helvoort A,. Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Eur Urol 2005; 48: 922-30; discussion 30-1.
13. Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR,. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA 2008; 105: 8369-74.
14. Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, van Breemen R, Ashton D, Bowen PE,. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 2001; 93: 1872-9.
15. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR,. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 2004; 171: 1393-401.
16. Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R, Carroll PR,. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research. Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1996; 48: 773-7.
17. Longnecker MP, Lissner L, Holden JM, Flack VF, Taylor PR, Stampfer MJ, Willett WC,. The reproducibility and validity of a self-administered semiquantitative food frequency questionnaire in subjects from South Dakota and Wyoming. Epidemiology 1993; 4: 356-65.
18. Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S,. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol 2001; 154: 1089-99.
19. Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, Willett WC,. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993; 93: 790-6.
20. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P,. Prostate specific antigen best practice statement: 2009 update. J Urol 2009; 182: 2232-41.
21. Grossfeld GD, Li YP, DP PL, Carroll PR,. Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy. Urology 2002; 60: 57-62; discussion 62-3.
22. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR, Cancer of the Prostate Strategic Urological Research E. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 2008; 112: 307-14.
23. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM,. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 2011; 71: 3889-95.
24. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A,. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74.
25. Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML,. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. J Urol 2008; 179: 1354-60; discussion 60-1.
26. Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB,. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 2007; 99: 1200-9.
27. Steinbrecher A, Nimptsch K, Husing A, Rohrmann S, Linseisen J,. Dietary glucosinolate intake and risk of prostate cancer in the EPIC-Heidelberg cohort study. Int J Cancer 2009; 125: 2179-86.
28. Hayes JD, Kelleher MO, Eggleston IM,. The cancer chemopreventive actions of phytochemicals derived from glucosinolates. Eur J Nutr 2008; 47 (Suppl 2): 73-88.
29. Hecht SS,. Chemoprevention by isothiocyanates. J Cell Biochem Suppl 1995; 22: 195-209.
30. Higdon JV, Delage B, Williams DE, Dashwood RH,. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 2007; 55: 224-36.
31. Shertzer HG, Senft AP,. The micronutrient indole-3-carbinol: implications for disease and chemoprevention. Drug Metabol Drug Interact 2000; 17: 159-88.
32. Clarke JD, Dashwood RH, Ho E,. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett 2008; 269: 291-304.
33. Singh AV, Xiao D, Lew KL, Dhir R, Singh SV,. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 2004; 25: 83-90.
34. Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK, Kamath R, Brown KD, Zhang L, Baskaran R,. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 2004; 279: 25813-22.
35. Wang LG, Liu XM, Fang Y, Dai W, Chiao FB, Puccio GM, Feng J, Liu D, Chiao JW,. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Int J Oncol 2008; 33: 375-80.
36. Wang LG, Liu XM, Chiao JW,. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate. Carcinogenesis 2006; 27: 2124-32.
37. Xiao D, Singh SV,. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res 2007; 67: 2239-46.
38. Hu J, Straub J, Xiao D, Singh SV, Yang HS, Sonenberg N, Vatsyayan J,. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1. Cancer Res 2007; 67: 3569-73.
39. Sarkar FH, Li Y,. Indole-3-carbinol and prostate cancer. J Nutr 2004; 134: 3493S-8S.
40. Chinni SR, Sarkar FH,. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res 2002; 8: 1228-36.
41. Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH,. Indole-3-carbinol (I3C) induced cell growth inhibition. G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 2001; 20: 2927-36.
42. Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E,. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood) 2007; 232: 227-34.
43. Traka M, Gasper AV, Melchini A, Bacon JR, Needs PW, Frost V, Chantry A, Jones AM, Ortori CA, Barrett DA, Ball RY, Mills RD, et al. Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One 2008; 3: e2568.
44. Joseph MA, Moysich KB, Freudenheim JL, Shields PG, Bowman ED, Zhang Y, Marshall JR, Ambrosone CB,. Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr Cancer 2004; 50: 206-13.
45. Herr I, Buchler MW,. Dietary constituents of broccoli and other cruciferous vegetables: implications for prevention and therapy of cancer. Cancer Treat Rev 2010; 36: 377-83.
46. Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, Al-Delaimy WK, Thomson CA, Kealey S, Hajek R, Parker BA, Newman VA, et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 2007; 25: 2345-51.
47. Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR,. Nutritional supplements. COX-2 and. IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control 2011; 22: 141-50.
48. Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN,. Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study. Int J Cancer 2008; 123: 927-32.
49. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA,. Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands. Cancer Epidemiol Biomarkers Prev 1998; 7: 673-80.
50. Yan L, Spitznagel EL,. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 2009; 89: 1155-63.